Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Weber

Showing results (231-240 of 341) with videos related to

Pageof 35
Sort By:
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 15, 2024
Novel approaches to define responders to interventional treatment in hypertension: insights from the SPYRAL HTN-OFF and HTN-ON MED trialsRoland E Schmieder, Douglas A Hettrick, Michael Böhm, et al.
Hypertension (Dallas, Tex. : 1979)|July 2, 2019
Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation TherapyKazuomi Kario, Michael A Weber, Felix Mahfoud, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 1, 2022
Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trialFlorian Rader, Ajay J Kirtane, Yale Wang, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 18, 2012
Association of Clinical Researchers and Educators a statement on relationships between physicians and industryMichael A Weber, Henry R Black, Rafael Fonseca, et al.
Hypertension (Dallas, Tex. : 1979)|December 30, 2010
Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure controlKenneth A Jamerson, Richard Devereux, George L Bakris, et al.
Circulation. Cardiovascular Interventions|May 20, 2025
Long-Term Safety and Efficacy of Renal Denervation: 24-Month Results From the SPYRAL HTN-ON MED TrialDavid E Kandzari, Felix Mahfoud, Raymond R Townsend, et al.
Hypertension (Dallas, Tex. : 1979)|June 30, 2016
Is It Time to Reappraise Blood Pressure Thresholds and Targets? A Statement From the International Society of Hypertension-A Global PerspectiveMichael A Weber, Neil R Poulter, Aletta E Schutte, et al.
Blood Pressure Monitoring|March 27, 2018
A strategy utilizing ambulatory monitoring and home and clinic blood pressure measurements to optimize the safety evaluation of noncardiovascular drugs with potential for hemodynamic effects: a report from the SYNERGY trialMichael A Weber, Christopher R Chapple, Christian Gratzke, et al.
Journal of Hypertension|September 27, 2012
Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapyMichael A Weber, Stevo Julius, Sverre E Kjeldsen, et al.
Circulation. Cardiovascular Quality and Outcomes|October 2, 2014
β-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trialSripal Bangalore, Deepak L Bhatt, Ph Gabriel Steg, et al.
Pageof 35

Showing results (231-240 of 341) with videos related to

Sort By:
Pageof 35
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 15, 2024
Novel approaches to define responders to interventional treatment in hypertension: insights from the SPYRAL HTN-OFF and HTN-ON MED trialsRoland E Schmieder, Douglas A Hettrick, Michael Böhm, et al.
Hypertension (Dallas, Tex. : 1979)|July 2, 2019
Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation TherapyKazuomi Kario, Michael A Weber, Felix Mahfoud, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 1, 2022
Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trialFlorian Rader, Ajay J Kirtane, Yale Wang, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 18, 2012
Association of Clinical Researchers and Educators a statement on relationships between physicians and industryMichael A Weber, Henry R Black, Rafael Fonseca, et al.
Hypertension (Dallas, Tex. : 1979)|December 30, 2010
Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure controlKenneth A Jamerson, Richard Devereux, George L Bakris, et al.
Circulation. Cardiovascular Interventions|May 20, 2025
Long-Term Safety and Efficacy of Renal Denervation: 24-Month Results From the SPYRAL HTN-ON MED TrialDavid E Kandzari, Felix Mahfoud, Raymond R Townsend, et al.
Hypertension (Dallas, Tex. : 1979)|June 30, 2016
Is It Time to Reappraise Blood Pressure Thresholds and Targets? A Statement From the International Society of Hypertension-A Global PerspectiveMichael A Weber, Neil R Poulter, Aletta E Schutte, et al.
Blood Pressure Monitoring|March 27, 2018
A strategy utilizing ambulatory monitoring and home and clinic blood pressure measurements to optimize the safety evaluation of noncardiovascular drugs with potential for hemodynamic effects: a report from the SYNERGY trialMichael A Weber, Christopher R Chapple, Christian Gratzke, et al.
Journal of Hypertension|September 27, 2012
Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapyMichael A Weber, Stevo Julius, Sverre E Kjeldsen, et al.
Circulation. Cardiovascular Quality and Outcomes|October 2, 2014
β-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trialSripal Bangalore, Deepak L Bhatt, Ph Gabriel Steg, et al.
Pageof 35